Stephen Kanes, Chief Medical Officer at Sage Therapeutics, Inc. (SAGE), bought 3,000 shares at $18.00 ($54K) on 2014-07-23, disclosed to the SEC on 2014-07-23.
Open-market purchase of $54k SAGE by Chief Medical Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| SAGE | SELL | 2016-04-21 | $798K | — | Filing → |
| SAGE | SELL | 2015-09-29 | $279K | — | Filing → |
| SAGE | SELL | 2015-09-01 | $637K | — | Filing → |